Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Liraglutide reduces risk of cardiovascular death in type 2 diabetes

Risk of cardiovascular death was reduced by 22% among patients who received liraglutide compared with placebo.

Although liraglutide has been shown to be effective in lowering blood glucose levels, its effect on cardiovascular outcomes has not been established. 

In a study published in The New England Journal of Medicine (online, 13 June 2016)[1], 9,340 patients with type 2 diabetes and high cardiovascular risk were randomly assigned to liraglutide or placebo. 

Over a median follow-up of 3.8 years, significantly fewer patients in the liraglutide group reached the primary composite outcome of death from cardiovascular causes, non-fatal myocardial infarction or non-fatal stroke than in the placebo group (13.0% vs 14.9%). Overall, the risk of cardiovascular death was reduced by 22% among patients who received liraglutide. 

The researchers say the findings show that liraglutide treatment can not just lower blood glucose, it can also help prevent some of the most negative outcomes associated with diabetes.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201367

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Application and Review of Pediatric Pharmacotherapy

    Application and Review of Pediatric Pharmacotherapy

    Increase your understanding of pharmacotherapy prescribed to pediatric patients with these realistic case studies.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.